Clinical trials
Infusion clinical trials
Below are recruiting infusion clinical trials, each written for real people, not researchers. We’re tracking 512 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05952310Recruiting
NK cell infusion for children and young adults with sarcoma
This trial tests an infusion of activated NK cells (a type of immune cell) to treat sarcomas that are still detectable or not responding well to standard treatment. If you qualify, you may receive this cell therapy while doctors closely check your organ function and heart strength.
MadridAges Up to 30 years - NCT06072989RecruitingPhase 1
B4T2-001 CAR-T infusions for solid tumors without chemo
This trial tests a new kind of cell therapy called CAR-T that targets a protein called BT-001 on solid tumors. It uses repeat infusions and avoids the strong chemotherapy usually given before treatment, which may be easier to tolerate.
Shanghai, China/ShanghaiAges 18–70 - NCT05451784RecruitingPhase 1/Phase 2
PD-1 TIL therapy for advanced triple-negative breast cancer
This study tests an immune-cell treatment made from your tumor tissue. It aims to help people with advanced or metastatic triple-negative breast cancer by collecting PD-1–positive immune cells and giving them back after treatment.
BarcelonaAges 18 years+ - NCT06201065RecruitingPhase 3
Targeted therapy and immunotherapy for advanced liver cancer
This trial tests a combination of two drugs (lenvatinib and toripalimab, a type of immunotherapy) plus a special chemotherapy infusion directly into the liver artery for people with advanced liver cancer that has not been treated before. The goal is to see if adding the immunotherapy helps shrink tumors better than the standard combination.
Guangzhou, GuangdongAges 18–75 - NCT06244225RecruitingPhase 2
Triple therapy for advanced liver cancer (HAIC + sintilimab + donafenib)
This trial tests a combination of three treatments for advanced liver cancer that cannot be removed by surgery: a targeted oral drug (Donafenib), an immunotherapy (Sintilimab), and a type of chemotherapy given directly into the liver artery. The goal is to see if this triple therapy works better than current options for people who have not had any prior cancer treatment.
Wuhan, HubeiAges 18 years+ - NCT04282044RecruitingPhase 1
CRX100 drug trial for advanced cancers with or without pembrolizumab
This Phase 1 trial tests CRX100 (a new cancer medicine) alone and with pembrolizumab (an immune checkpoint drug) in people with advanced solid tumors. It’s mainly designed to check safety and side effects, and to see whether tumors respond, potentially helping people whose cancer has come back or stopped responding to standard treatment.
Scottsdale, ArizonaAges 18 years+ - NCT07855640Recruiting
Immunotherapy plus chemo for advanced stomach cancer with fluid in belly
This trial tests a new combination for advanced stomach cancer that has spread and caused fluid buildup in the belly (malignant ascites). It combines an immunotherapy drug (anti-PD-1) with standard chemotherapy and a targeted chemotherapy given directly into the belly to see if it can shrink the cancer and help you feel better.
Hangzhou, ZhejiangAges 18–75 - NCT07867769RecruitingPhase 2
Comparing two cell treatments for children needing a stem cell transplant
This study tests two ways to prepare donated blood cells for children who need a stem cell transplant but don't have a perfectly matched sibling donor. The aim is to reduce side effects and improve outcomes.
Hong KongAges Up to 18 years - NCT07867899Recruiting
Preventing confusion after hip fracture surgery
This study tests whether a medication called dexmedetomidine, given during or after hip fracture surgery, can help prevent confusion (delirium) that sometimes occurs in older patients after surgery. If you are 65 or older and having hip fracture surgery, this treatment might help you recover more clearly.
AarhusAges 65 years+ - NCT07868861RecruitingPhase 1
Nasal ondansetron versus IV injection in healthy adults
This trial tests a new nasal spray form of ondansetron (a medicine that prevents nausea and vomiting) to see how well the body absorbs it compared with the IV (into the vein) form. It is for healthy adults to help understand how the nasal spray works.
JerusalemAges 18–65 - NCT06101082RecruitingPhase 1
Testing anti-HER2-CAR-T cells for advanced solid tumors
This study tests a new type of cell therapy called anti-HER2-CAR-T for people with advanced HER2-positive solid tumors (like breast, stomach, or colon cancer) whose cancer has not responded to other treatments. The therapy uses your own immune cells engineered to target and kill cancer cells.
Shenyang, LiaoningAges 18–70 - NCT05677152RecruitingPhase 2
Anti-bone-drug test to help shoulder tendon healing after surgery
This Phase 2 trial studies whether an anti-osteoporosis medicine (zoledronic acid) can improve healing after surgery for a chronic rotator cuff tear in the shoulder. If you qualify, you would also follow a specific 4-week physical therapy plan using a shoulder support pad.
ViennaAges 50–70 - NCT06196788RecruitingPhase 2
Artery infusion chemo for advanced pancreatic cancer
This trial tests a treatment called transcatheter arterial infusion, where chemotherapy drugs are delivered directly to the tumor through a thin tube in an artery. It's for people with advanced pancreatic cancer who haven't had other treatments yet.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT05686538RecruitingPhase 2/Phase 3
Study of donor immune cells after stem cell transplant for AML/MDS
This trial tests whether infusing donor immune cells after a stem cell transplant can help treat AML or MDS. It involves donating and receiving a specific type of immune-cell infusion, with safety checks around the donor’s procedure.
CopenhagenAges 18–80 - NCT06406634RecruitingPhase 2
Cadonilimab, Lenvatinib, and HAIC for Unresectable Liver Cancer
This trial tests a combination of three treatments for advanced liver cancer that can't be removed by surgery. It uses an immunotherapy drug (cadonilimab), a targeted therapy pill (lenvatinib), and a direct chemotherapy infusion into the liver (HAIC). The goal is to see if this combo can shrink tumors and improve outcomes.
Changsha, HunanAges 18–75 - NCT03476213Recruiting
Compare two anesthesia infusion methods after brain tumor surgery
This trial compares two ways of giving anesthesia during brain tumor surgery to see how they affect awareness and dreaming after surgery. It may help doctors choose a method that improves comfort while keeping patients safely asleep and recovering normally.
Hradec KrálovéAges 18 years+ - NCT05233722Recruiting
Study of how mTOR affects insulin sensitivity in healthy men
This study looks at whether a body pathway called mTOR helps control how your body handles insulin and blood sugar. It’s done in healthy men to understand insulin sensitivity before testing approaches in people with health problems later.
CopenhagenAges 22–35 - NCT05646550RecruitingPhase 1
Antibody CC-1 for men with returning prostate cancer
This Phase 1 study tests an antibody drug (CC-1) for men whose prostate cancer has come back, based on rising PSA blood tests. It looks at safety and how the treatment affects cancer activity, especially whether it can help control early biochemical recurrence.
TübingenAges 18 years+ - NCT07847359RecruitingPhase 2
Freezing and drug combination for melanoma that has spread to the liver
This trial tests a combination of treatments for melanoma that has spread to the liver after standard treatment. It uses freezing (cryoablation), a targeted drug (lenvatinib), chemotherapy (dacarbazine), and two immunotherapy drugs to try to shrink liver tumors and control the cancer. The goal is to see if this combined approach is safe and effective for patients whose cancer has not responded to prior therapy.
Guangzhou, GuangdongAges 18–75 - NCT06407947RecruitingEarly Phase 1
CT071 for high-risk newly diagnosed multiple myeloma
This trial tests an experimental therapy called CT071 for people with newly diagnosed, high-risk multiple myeloma. It aims to see if this treatment can help control the disease in people who have certain aggressive features.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07841574RecruitingPhase 2
Combination treatment for bile duct cancer in the liver
This trial tests a new combination of treatments for intrahepatic cholangiocarcinoma (a bile duct cancer in the liver) that cannot be surgically removed. It combines chemo directly into the liver with two drugs that boost the immune system and block blood vessel growth, hoping to shrink the tumor and help you live longer.
Guangzhou, GuangdongAges 18–75 - NCT07826533Recruiting
Intravenous papaverine for term prelabour rupture of membranes
This study tests whether giving papaverine through a vein can help start labour in women whose water has broken but who are not yet having contractions. Papaverine is a medicine that relaxes smooth muscles, which may help the cervix prepare for delivery.
HolonAges Any age - NCT03755739RecruitingPhase 2/Phase 3
Checkpoint cancer drug given into or near tumors
This trial studies whether giving immunotherapy “checkpoint inhibitor” medicine directly into the tumor area (and/or the artery feeding it), along with a chemotherapy-style drug, can work better for advanced solid tumors. It aims to boost the immune system’s ability to attack cancer while still being safe for people with measurable tumors.
Guanzhou, GuangdongAges 18 years+ - NCT03952065RecruitingPhase 2/Phase 3
Neck artery immune-therapy vs IV for head and neck cancer
This trial compares giving immune therapy into the neck artery versus giving it through a vein (IV) for people with head and neck cancers. It aims to see which method works better and is safer by helping the immune system attack the cancer.
Guanzhou, GuangdongAges 18–80
Hear when a new Infusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infusion?
- Yes. Clin2 currently lists 512 recruiting infusion studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infusion trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infusion trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.